Crossmark

When is iron overload deleterious, and when and how should iron chelation therapy be administered in myelodysplastic syndromes?

Crossref DOI link: https://doi.org/10.1016/j.beha.2013.09.009

Published Print: 2013-12

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Steensma, David P.

Gattermann, Norbert
More Information

This article is maintained by: Elsevier

Article Title: When is iron overload deleterious, and when and how should iron chelation therapy be administered in myelodysplastic syndromes?

Journal Title: Best Practice & Research Clinical Haematology

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.beha.2013.09.009

Content Type: article

Copyright: Copyright © 2013 Elsevier Ltd. All rights reserved.